Crexendo (CXDO) Q3 2026 Earnings Call Transcript

Crexendo reported Q3 2026 revenue of $25.2 million, up 44% year over year, reaching a $100 million annualized run rate; adjusted EBITDA rose to $4.0 million from $2.9 million. Year-to-date platform wins reached 16, above the 14 added in all of 2025, while remaining performance obligations increased 59% year over year to $139.6 million. Offsetting strengths, organic revenue growth was 5% for the quarter and 9.1% year to date—below its double-digit goal—and management said interest-rate uncertainty is weighing on upgrade orders; it did not provide 2027 organic growth guidance.

Analysis

The key underwriting split is acquisition-led scale versus still-modest organic momentum: consolidated growth overstates current platform demand, while the software segment’s low-single-digit growth leaves the thesis dependent on licensee migrations eventually becoming capacity upgrades and recurring attach revenue. New-logo counts are encouraging, but small initial deployments and financing-sensitive upgrades can create a long lag between a win and material revenue. RPO supports visibility, not the timing or margin of conversion.

Near term (days to 1–3 months), the risk is that investors capitalize the $100M run rate and logo momentum before organic growth or operating leverage confirms it. Watch Q4 organic growth, software revenue, upgrade orders, and cash conversion; higher reported growth alone is not enough. Over 6–18 months, Flow’s first-half-2027 launch and AI monetization could improve retention and cross-sell, but management’s own timing makes AI a poor near-term earnings catalyst. Third-party dependence also limits differentiation and leaves economics contingent on adoption and revenue-sharing terms.

The contrarian opportunity is that rate-sensitive upgrade deferrals may be delayed demand rather than lost demand; if financing conditions ease, migrations could produce a nonlinear capacity-revenue tailwind. Conversely, that recovery is not yet evidenced, and acquisition integration, rising receivables from device leases, and cash earmarked for M&A could weaken cash conversion. Treat management’s lifetime-value claims and pipeline enthusiasm as hypotheses pending cohort-level conversion data. Cisco’s legacy BroadSoft platform is part of the competitive backdrop, but this call does not imply a material earnings effect for Cisco Systems.

Key Decisions for Investors

• Do not chase CXDO solely on headline growth or logo wins. Consider a small, staged long only on weakness and after checking valuation and post-call price action; the catalyst is evidence in Q4/next results that organic growth and upgrade bookings are improving. No defensible price target is available from the supplied data.
• Falsify the constructive thesis if organic growth remains around or below the reported 5% level, software growth stays weak, or RPO declines without corresponding revenue conversion. Reassess on upgrade bookings, customer migration pace, and segment margins—not total revenue alone.
• Keep Flow and AI as 2027 optionality, not near-term earnings estimates. Verify launch timing, paid adoption, attach rates, and revenue contribution before underwriting incremental multiple expansion.
• Monitor cash conversion and acquisition discipline: obtain updated debt, lease-receivable, working-capital, and acquisition-spend details. If cash generation deteriorates while M&A continues, the growth narrative carries greater balance-sheet and dilution risk.